BE871298A - Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese - Google Patents

Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese

Info

Publication number
BE871298A
BE871298A BE191150A BE191150A BE871298A BE 871298 A BE871298 A BE 871298A BE 191150 A BE191150 A BE 191150A BE 191150 A BE191150 A BE 191150A BE 871298 A BE871298 A BE 871298A
Authority
BE
Belgium
Prior art keywords
lipoproteic
vitamin
effectiveness
synthetic antioxidants
normalizing
Prior art date
Application number
BE191150A
Other languages
English (en)
Inventor
P J Bugard
M C G A Henry
J J A Jagu
Original Assignee
Bugard Pierre J
Henry Michel C G A
Jagu Jacques J A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bugard Pierre J, Henry Michel C G A, Jagu Jacques J A filed Critical Bugard Pierre J
Publication of BE871298A publication Critical patent/BE871298A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01013—Sterol esterase (3.1.1.13)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004—Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE191150A 1978-10-11 1978-10-16 Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese BE871298A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7829073A FR2438481A1 (fr) 1978-10-11 1978-10-11 Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese

Publications (1)

Publication Number Publication Date
BE871298A true BE871298A (fr) 1979-02-15

Family

ID=9213628

Family Applications (1)

Application Number Title Priority Date Filing Date
BE191150A BE871298A (fr) 1978-10-11 1978-10-16 Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese

Country Status (2)

Country Link
BE (1) BE871298A (fr)
FR (1) FR2438481A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198432A (en) * 1988-01-29 1993-03-30 Center For Innovative Technology Method of preventing chlorohydrocarbon toxicity using sterol derivatives

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614205A2 (fr) * 1978-10-11 1988-10-28 Bugard Pierre Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese.
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
FR2715070B1 (fr) * 1994-01-18 1996-02-09 Codif International Sa Produit à activité lipolyptique et sa méthode de préparation.
EA000210B1 (ru) * 1996-04-08 1998-12-24 Российский Университет Дружбы Народов Препарат, защищающий печень при вирусном гепатите

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES296810A1 (es) * 1963-08-07 1964-05-01 H C Burns Company Inc Procedimiento de fabricaciën de un preparado para el tratamiento y control de ciertas enfermedades regenerativas metabëlicas

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198432A (en) * 1988-01-29 1993-03-30 Center For Innovative Technology Method of preventing chlorohydrocarbon toxicity using sterol derivatives

Also Published As

Publication number Publication date
FR2438481A1 (fr) 1980-05-09
FR2438481B1 (fr) 1981-05-29

Similar Documents

Publication Publication Date Title
BE873587A (fr) Systeme d'identification personnelle
BE852195A (fr) Matieres alimentaires pour l'homme et pour les animaux
IT8047806A0 (it) Impiego di benzofuran-2-oni e/o indolin-2-oni come antiossidanti
ATA908281A (de) Kompakte tierfutterergaenzungs-zusammensetzung
DK32982A (da) Terapeutisk nyttige tetralinderivater
AR240922A1 (es) "procedimiento para preparar acilureidoalquil-bencensulfo-nilureas".
ES516574A0 (es) "aparato para separar granulocitos de sangre completa".
IT7851783A0 (it) Sistema per l'applicazione di rivetti senza testa
KR880700663A (ko) 망으로 부터 얻은 지질 및 이것을 화장품으로 사용하기 위한 방법
MA19046A1 (fr) Nouveau derive d'acides i-(cyclohexyl) -4-aryl-4-piperidinecarboxylique .
FR2495635B1 (fr) Production d'urokinase humaine
FI842697A7 (fi) Kosmeettinen valmiste.
IT1193657B (it) Dispositivo segnalatore dell'usura delle guarnizioni su ganasce di frenatura
IT1192763B (it) Composizione di lubrificazione e separazione per fucinatura isotermica
AT382075B (de) Hautpflegemittel
ES514346A0 (es) "dispositivo para cerrar canales corporales".
IT1193972B (it) Impianto per la rivelazione dell'inviluppo di un segnale
FR2557936B1 (fr) Attache borgne
FR2336945A1 (fr) Composition pour la sterilisation des femmes et des femelles d'animaux
IT1153998B (it) Radioanalisi simultanea di folato e vitamina b 129
DE3669497D1 (de) Cycloalkan-1-ol derivate und duftstoff-zusammensetzungen, die diese enthalten.
IT1134573B (it) Dispositivo per l'espulsione di articoli
TR21851A (tr) Haloasetamidin'ler ve bunlarin herbisid olarak kullanilmasi
IT1172075B (it) Prodotto cosmetico
DE3372612D1 (de) Use of substituted malonic-acid derivatives as pesticides

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BUGARD PIERRE J.

Effective date: 19901031

Owner name: HENRY MICHEL C. G. A.

Effective date: 19901031

Owner name: JAGU JACQUES J. A.

Effective date: 19901031